- Home
- LTBR vs DTIL Comparison
LTBR vs DTIL Comparison
Compare LTBR & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- DTIL
- Stock Information
- Founded
- LTBR 1992
- DTIL 2006
- Country
- LTBR United States
- DTIL United States
- Employees
- LTBR N/A
- DTIL N/A
- Industry
- LTBR Professional Services
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- LTBR Consumer Discretionary
- DTIL Health Care
- Exchange
- LTBR Nasdaq
- DTIL Nasdaq
- Market Cap
- LTBR 45.5M
- DTIL 44.1M
- IPO Year
- LTBR N/A
- DTIL 2019
- Fundamental
- Price
- LTBR $8.03
- DTIL $5.08
- Analyst Decision
- LTBR
- DTIL Strong Buy
- Analyst Count
- LTBR 0
- DTIL 3
- Target Price
- LTBR N/A
- DTIL $37.67
- AVG Volume (30 Days)
- LTBR 2.0M
- DTIL 1.2M
- Earning Date
- LTBR 02-26-2025
- DTIL 11-04-2024
- Dividend Yield
- LTBR N/A
- DTIL N/A
- EPS Growth
- LTBR N/A
- DTIL N/A
- EPS
- LTBR N/A
- DTIL 1.45
- Revenue
- LTBR N/A
- DTIL $75,096,000.00
- Revenue This Year
- LTBR N/A
- DTIL $51.35
- Revenue Next Year
- LTBR N/A
- DTIL N/A
- P/E Ratio
- LTBR N/A
- DTIL $3.49
- Revenue Growth
- LTBR N/A
- DTIL 43.62
- 52 Week Low
- LTBR $2.21
- DTIL $3.61
- 52 Week High
- LTBR $14.20
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- LTBR 59.94
- DTIL 48.91
- Support Level
- LTBR $5.12
- DTIL $4.50
- Resistance Level
- LTBR $10.45
- DTIL $7.44
- Average True Range (ATR)
- LTBR 1.08
- DTIL 0.59
- MACD
- LTBR 0.39
- DTIL 0.09
- Stochastic Oscillator
- LTBR 55.51
- DTIL 19.73
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through Nuclear Fuel Technology segment. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.